Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
02 12 2020
Historique:
entrez: 7 12 2020
pubmed: 8 12 2020
medline: 4 11 2021
Statut: epublish

Résumé

Multiple myeloma is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. This manuscript discusses the management of patients with solitary plasmacytoma, smoldering multiple myeloma, and newly diagnosed multiple myeloma.

Identifiants

pubmed: 33285522
doi: 10.6004/jnccn.2020.0057
pii: jnccnGLS1812
doi:
pii:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

1685-1717

Auteurs

Shaji K Kumar (SK)

1Mayo Clinic Cancer Center.

Natalie S Callander (NS)

2University of Wisconsin Carbone Cancer Center.

Kehinde Adekola (K)

3Robert H. Lurie Comprehensive Cancer of Center Northwestern University.

Larry Anderson (L)

4UT Southwestern Simmons Comprehensive Cancer Center.

Muhamed Baljevic (M)

5Fred & Pamela Buffett Cancer Center.

Erica Campagnaro (E)

6University of Michigan Rogel Cancer Center.

Jorge J Castillo (JJ)

7Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center.

Jason C Chandler (JC)

8St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.

Caitlin Costello (C)

9UC San Diego Moores Cancer Center.

Yvonne Efebera (Y)

10The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Matthew Faiman (M)

11Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Alfred Garfall (A)

12Abramson Cancer Center at the University of Pennsylvania.

Kelly Godby (K)

13O'Neal Comprehensive Cancer Center at UAB.

Jens Hillengass (J)

14Roswell Park Comprehensive Cancer Center.

Leona Holmberg (L)

15Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Myo Htut (M)

16City of Hope National Medical Center.

Carol Ann Huff (CA)

17The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Yubin Kang (Y)

18Duke Cancer Institute.

Malin Hultcrantz (M)

19Memorial Sloan Kettering Cancer Center.

Sarah Larson (S)

20UCLA Jonsson Comprehensive Cancer Center.

Michaela Liedtke (M)

21Stanford Cancer Institute.

Thomas Martin (T)

22UCSF Helen Diller Family Comprehensive Cancer Center.

James Omel (J)

23Patient Advocate.

Kenneth Shain (K)

24Moffitt Cancer Center.

Douglas Sborov (D)

25Huntsman Cancer Institute at the University of Utah.

Keith Stockerl-Goldstein (K)

26Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Donna Weber (D)

27The University of Texas MD Anderson Cancer Center; and.

Jennifer Keller (J)

28National Comprehensive Cancer Network.

Rashmi Kumar (R)

28National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH